<code id='AB6FC69B46'></code><style id='AB6FC69B46'></style>
    • <acronym id='AB6FC69B46'></acronym>
      <center id='AB6FC69B46'><center id='AB6FC69B46'><tfoot id='AB6FC69B46'></tfoot></center><abbr id='AB6FC69B46'><dir id='AB6FC69B46'><tfoot id='AB6FC69B46'></tfoot><noframes id='AB6FC69B46'>

    • <optgroup id='AB6FC69B46'><strike id='AB6FC69B46'><sup id='AB6FC69B46'></sup></strike><code id='AB6FC69B46'></code></optgroup>
        1. <b id='AB6FC69B46'><label id='AB6FC69B46'><select id='AB6FC69B46'><dt id='AB6FC69B46'><span id='AB6FC69B46'></span></dt></select></label></b><u id='AB6FC69B46'></u>
          <i id='AB6FC69B46'><strike id='AB6FC69B46'><tt id='AB6FC69B46'><pre id='AB6FC69B46'></pre></tt></strike></i>

          leisure time

          leisure time

          author:hotspot    Page View:433
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          ASCO Daily Recap: Safety data from Novartis, survival from Pfizer
          ASCO Daily Recap: Safety data from Novartis, survival from Pfizer

          ADAMFEUERSTEIN/STATYou’rereadingthewebeditionofASCOin30Seconds,STAT’sguidetotheAmericanSocietyofClin

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Pharma budget tightening trickles down to Doximity

          AdobeYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Sign